… randomized controlled trials demonstrating mortality reduction, many studies have documented
persistent low rates of prescription of angiotensin-converting enzyme inhibitors (ACE-I) …

… Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors
on mortality … Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: …

… of ACE inhibitors on mortality and province. Furthermore, we tested in separate models
whether the differences in mortality among users of individual ACE inhibitors were modified by …

… Our study examined the class effect of ACE inhibitors on 1-year mortality when the ACE
inhibitors were prescribed to elderly patients immediately after acute myocardial infarction. …

… Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and
morbidity in patients with heart failure. JAMA 1995;273:1450–6. w2x Flather MD, Yusuf S, …

… Angiotensinconverting enzyme (ACE) inhibitor therapy is essential … inhibitors reduce mortality
rates, hospitalization, and morbidity in severe heart failure.~ The benefits of ACE inhibitors …

… hospitals in 1995, evaluated determinants of ACE inhibitor prescription, and compared the
… large ACE inhibitor mortality tiials.s,X Thus, there is limited information on the impact of ACE …

… Angiotensin-converting enzyme inhibitors reduce mortality substantially in patients with
myocardial infarction with ejection fraction less than 40% but demonstrate only mildly protective …

… enzyme inhibitor nonuse than seen in previous populations. This study examines
angiotensin-converting enzyme inhibitor … rate of angiotensin-converting enzyme inhibitor …

… Outpatient medications were not captured in the data collection; thus, the influence of lipid-reducing
agents, aspirin, -blockers, and angiotensin-converting enzyme inhibitors were not …